Key Metrics
5.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Oncology
SJR
- Q2 Oncology
- Q3 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.99
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Cancer
- Peripheral blood
- Curcumin
- Lung cancer
- Progression-free survival
- Immunotherapy
- Radiosurgery
- Western blot
- Breast cancer
- Hepatocellular carcinoma
- Multivariate analysis
- Overall survival
- Melatonin
- Prostate cancer
- Toxicity
- Medical physics
- Colorectal cancer
- Adjuvant
- Cell growth
- Clinical significance
Journal Specifications
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Clinical and Translational Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Prevalence and impact of metabolic associated fatty liver disease innon‑metastatic breast cancer women at initial diagnosis: a cross‑sectional study in China: a letter to the editor.
- 7 Dec 24
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
-
Full paper
Correction: The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors.
- 5 Dec 24
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
-
Full paper
Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain.
- 5 Dec 24
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
-
Full paper
CXCR2 expression is associated with prostate-specific membrane antigen expression in hepatocellular carcinoma: reappraisal of tumor microenvironment and angiogenesis.
- 5 Dec 24
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
-
Full paper
Cancer and physical activity: facilitating counseling.
- 3 Dec 24
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
-
Full paper
Diverse RNA methylation patterns in neutrophils: key drivers in hepatocellular carcinoma.
- 2 Dec 24
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Scite analysis
Powered by scite_
4k articles received 37.5k citations see all
- 1,424 Supporting
- 34,746 Mentioning
- 228 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 50 Corrections
- 51 Errata
- 1 Expression of Concern
FAQs
How long has Clinical and Translational Oncology been actively publishing?
Clinical and Translational Oncology has been in operation since 1999 till date.
What is the publishing frequency of Clinical and Translational Oncology ?
Clinical and Translational Oncology published with a Monthly frequency.
How many articles did Clinical and Translational Oncology publish last years ?
In 2023, Clinical and Translational Oncology published 305 articles.
What is the eISSN & pISSN for Clinical and Translational Oncology ?
For Clinical and Translational Oncology,eISSN is 1699-3055 and pISSN is1699-048X.
What is Citescore for Clinical and Translational Oncology ?
Citescore for Clinical and Translational Oncology is 5.5.
What is SNIP score for Clinical and Translational Oncology ?
SNIP score for Clinical and Translational Oncology is 0.99.
What is the SJR for Clinical and Translational Oncology ?
SJR for Clinical and Translational Oncology is Q3.
Who is the publisher of Clinical and Translational Oncology ?
SPRINGER INT PUBL AG is the publisher of Clinical and Translational Oncology.